Latest Health News
US and Ethiopia Sign Bilateral Health Cooperation MOU
The United States and Ethiopia signed a Memorandum of Understanding under the America First Global Health Strategy launched in September 2025. This MOU serves as a model for sustainable health investment. It aims to strengthen bilateral health cooperation amid global health challenges.
Breakthrough in TIGIT and PD-1 Immunotherapy for Cancer
University of Sharjah researchers reviewed TIGIT, an immune checkpoint protein that suppresses immune attacks on cancer cells, and its synergy with PD-1. Combining inhibitors of both proved more effective in restoring immune response against tumors. Future strategies include bispecific antibodies, small molecules, and TIGIT-resistant CAR-T cells, though biomarkers for patient selection remain needed.
UWI and PAHO Boost Infectious Disease Diagnostics
The University of the West Indies and PAHO strengthened regional collaboration on infectious disease diagnostics and genomic surveillance. This partnership enhances capabilities in the Americas amid ongoing health threats. It builds on PAHO's 2025 progress in protecting regional health.
2025 Oncology Year in Review: AI and Liquid Biopsies
2025 saw transformative oncology advances including AI for predicting immunotherapy responses in lung cancer and imaging diagnostics across multiple cancers. Liquid biopsies advanced for early detection, with multi-cancer tests showing 10-34% more stage 1-3 diagnoses in simulations. Debates continue on clinical adoption for monitoring and multi-cancer early detection (MCED).
Climate Change Exacerbates Global Health Risks
Rising temperatures, heatwaves, air pollution, and climate-sensitive diseases are worsening health outcomes and human development. These factors interact with existing vulnerabilities, posing threats to global populations. Urgent adaptations are needed to mitigate impacts on health systems.
RSNA 2025: Precision Medicine and Physician Well-Being
RSNA 2025 highlighted imaging's role in precision health, from molecular disease characterization to opportunistic screening via CT, MR, PET, and US. Advances include the All of Us dataset with over 20,000 researchers contributing to 1,100 publications. Sessions addressed Alzheimer's imaging with amyloid/tau PET predicting cognitive decline.
US Foreign Aid Freeze Impacts Global Health
Early 2025 saw the US government freeze billions in foreign aid, affecting millions reliant on global health programs. This tumultuous event disrupted ongoing health initiatives worldwide. Recovery efforts continue into late 2025.
Record-Breaking Genome Sequencing for Newborns
A team from Roche, Broad Clinical Labs, and Boston Children's set a Guinness record for fastest genome sequencing at 3 hours 57 minutes, beating the prior 5-hour mark. Tested on NICU infants, it promises faster genetic interventions in neonatal care. Clinical applications could transform rapid diagnostics.
2025 Advances in Rare Disease Pharmacology
2025 marked a milestone in rare disease drug development with many long-anticipated therapies gaining approval after decades of progress. These advances expand treatment options for underserved patients globally. The year accelerated pharmacology innovations.
Hepatitis 2025: FDA Approvals and Breakthroughs
The year featured FDA approvals, breakthroughs in HBV and HDV treatments, HCV label expansions, updated clinical guidelines, and vaccine policy changes. These developments improved management of viral hepatitis worldwide. Progress enhances patient outcomes and prevention strategies.
Fred Hutch 2025: Therapeutic Genetic Engineering
Fred Hutchinson Cancer Center advanced therapeutic genetic engineering to cure diseases, addressing delivery cost and complexity challenges. 2025 highlights include potential for broader clinical applications. Year-in-pictures showcase key research milestones.